Literature DB >> 17308092

PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2.

Angela Glading1, James A Koziol, Joseph Krueger, Mark H Ginsberg.   

Abstract

Phosphoprotein enriched in astrocytes of 15 kDa (PEA-15) binds to extracellular signal-regulated kinase 1 and 2 (ERK1/2) mitogen-activated protein (MAP) kinases to alter ERK1/2 cellular localization and target preferences and binds to adaptors in the extrinsic cell death pathway to block apoptosis. Here, we report that PEA-15 protein expression is inversely correlated with the invasive behavior of breast cancer in an immunohistochemical analysis of a breast cancer progression tissue microarray. Short hairpin RNA-mediated inhibition of PEA-15 expression increased the invasion of PEA-15-expressing tumor cells in vitro, suggesting a causative role for PEA-15 in the inhibition of invasion. This causative role was confirmed by the finding that the enforced expression of PEA-15 in invasive tumor cells reduced invasion. The effect of PEA-15 on tumor invasion is mediated by its interaction with ERK1/2 as shown by the following: (a) PEA-15 mutants that fail to bind ERK1/2 did not inhibit invasion; (b) overexpression of ERK1 or activated MAP/ERK kinase (MEK) reversed the inhibitory effect of PEA-15; (c) when an inhibitor of ERK1/2 activation reduced invasion, PEA-15 expression did not significantly reduce invasion further. Furthermore, we find that the effect of PEA-15 on invasion seems to relate to the nuclear localization of activated ERK1/2. PEA-15 inhibits invasion by keeping ERK out of the nucleus, as a PEA-15 mutant that cannot prevent ERK nuclear localization was not able to inhibit invasion. In addition, membrane-localized ERK1, which sequesters endogenous ERK1 to prevent its nuclear localization, also inhibited invasion. These results reveal that PEA-15 regulates cancer cell invasion via its ability to bind ERK1/2 and indicate that nuclear entry of ERK1/2 is important in tumor behavior.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308092     DOI: 10.1158/0008-5472.CAN-06-1378

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  Expression of phosphoprotein enriched in astrocytes 15 kDa (PEA-15) in astrocytic tumors: a novel approach of correlating malignancy grade and prognosis.

Authors:  Yosuke Watanabe; Fumiyuki Yamasaki; Yoshinori Kajiwara; Taiichi Saito; Takeshi Nishimoto; Chandra Bartholomeusz; Naoto T Ueno; Kazuhiko Sugiyama; Kaoru Kurisu
Journal:  J Neurooncol       Date:  2010-05-09       Impact factor: 4.130

2.  PEA15 impairs cell migration and correlates with clinical features predicting good prognosis in neuroblastoma.

Authors:  Joanna E Gawecka; Dirk Geerts; Jan Koster; Maisel J Caliva; Florian J Sulzmaier; John Opoku-Ansah; Randal K Wada; André S Bachmann; Joe W Ramos
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

3.  Bisphosphorylated PEA-15 sensitizes ovarian cancer cells to paclitaxel by impairing the microtubule-destabilizing effect of SCLIP.

Authors:  Xuemei Xie; Chandra Bartholomeusz; Ahmed A Ahmed; Anna Kazansky; Lixia Diao; Keith A Baggerly; Gabriel N Hortobagyi; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2013-03-29       Impact factor: 6.261

4.  PEA15 regulates the DNA damage-induced cell cycle checkpoint and oncogene-directed transformation.

Authors:  Arvindhan Nagarajan; Shaillay Kumar Dogra; Alex Y Liu; Michael R Green; Narendra Wajapeyee
Journal:  Mol Cell Biol       Date:  2014-04-07       Impact factor: 4.272

5.  Next-Generation CDK2/9 Inhibitors and Anaphase Catastrophe in Lung Cancer.

Authors:  Masanori Kawakami; Lisa Maria Mustachio; Jaime Rodriguez-Canales; Barbara Mino; Jason Roszik; Pan Tong; Jing Wang; J Jack Lee; Ja Hye Myung; John V Heymach; Faye M Johnson; Seungpyo Hong; Lin Zheng; Shanhu Hu; Pamela Andrea Villalobos; Carmen Behrens; Ignacio Wistuba; Sarah Freemantle; Xi Liu; Ethan Dmitrovsky
Journal:  J Natl Cancer Inst       Date:  2017-06-01       Impact factor: 13.506

6.  Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.

Authors:  Yann Wallez; Stefan J Riedl; Elena B Pasquale
Journal:  J Biol Chem       Date:  2014-02-28       Impact factor: 5.157

7.  A functional and regulatory network associated with PIP expression in human breast cancer.

Authors:  Marie-Anne Debily; Sandrine El Marhomy; Virginie Boulanger; Eric Eveno; Régine Mariage-Samson; Alessandra Camarca; Charles Auffray; Dominique Piatier-Tonneau; Sandrine Imbeaud
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

Review 8.  How ERK1/2 activation controls cell proliferation and cell death: Is subcellular localization the answer?

Authors:  Yohannes Mebratu; Yohannes Tesfaigzi
Journal:  Cell Cycle       Date:  2009-04-11       Impact factor: 4.534

9.  PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival.

Authors:  Chandra Bartholomeusz; Daniel Rosen; Caimiao Wei; Anna Kazansky; Fumiyuki Yamasaki; Takeshi Takahashi; Hiroaki Itamochi; Seiji Kondo; Jinsong Liu; Naoto T Ueno
Journal:  Cancer Res       Date:  2008-11-15       Impact factor: 12.701

10.  Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2alpha.

Authors:  Jacob R Haling; Fen Wang; Mark H Ginsberg
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.